Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Shareholders' Equity (Unaudited)

v3.20.2
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Total Shareholders' Equity [Member]
Non-controlling Interest [Member]
Total
Beginning balance at Oct. 31, 2018 $ 189,086 $ 175,415,931 $ (170,170,209) $ 5,434,808 $ (251,377) $ 5,183,431
Beginning balance, shares at Oct. 31, 2018 18,908,632          
Stock option compensation to employees and directors 2,808,910 2,808,910 2,808,910
Stock options issued to consultants 139,161 139,161 139,161
Common stock issued upon exercise of stock options $ 400 102,100 102,500 102,500
Common stock issued upon exercise of stock options, shares 40,000          
Restricted stock award compensation to employee pursuant to stock incentive plan 1,954,441 1,954,441 1,954,441
Restricted stock award compensation to employee pursuant to stock incentive plan, shares          
Common stock issued pursuant to employee stock purchase plan $ 54 18,506 18,560 18,560
Common stock issued pursuant to employee stock purchase plan, shares 5,411          
Common stock issued in at-the-market offering, net of offering expenses $ 12,088 4,887,657 4,899,745 4,899,745
Common stock issued in at-the-market offering, net of offering expenses, shares 1,208,808          
Net loss (9,559,561) (9,559,561) (148,030) (9,707,591)
Ending balance at Jul. 31, 2019 $ 201,628 185,326,706 (179,729,770) 5,798,564 (399,407) 5,399,157
Ending balance, shares at Jul. 31, 2019 20,162,851          
Beginning balance at Apr. 30, 2019 $ 200,050 183,932,744 (177,589,742) 6,543,052 (373,387) 6,169,665
Beginning balance, shares at Apr. 30, 2019 20,005,075          
Stock option compensation to employees and directors 784,246 784,246 784,246
Common stock issued upon exercise of stock options $ 100 22,600 22,700 22,700
Common stock issued upon exercise of stock options, shares 10,000          
Common stock issued in at-the-market offering, net of offering expenses $ 1,478 540,464 541,942 541,942
Common stock issued in at-the-market offering, net of offering expenses, shares 147,776          
Stock options and warrants issued to consultants 46,652 46,652 46,652
Net loss (2,140,028) (2,140,028) (26,020) (2,166,048)
Ending balance at Jul. 31, 2019 $ 201,628 185,326,706 (179,729,770) 5,798,564 (399,407) 5,399,157
Ending balance, shares at Jul. 31, 2019 20,162,851          
Beginning balance at Oct. 31, 2019 $ 203,317 186,849,299 (181,817,263) 5,235,353 (422,975) 4,812,378
Beginning balance, shares at Oct. 31, 2019 20,331,754          
Stock option compensation to employees and directors 3,016,305 3,016,305 3,016,305
Stock options issued to consultants 156,914 156,914 156,914
Common stock issued upon exercise of stock options $ 511 121,759 122,270 122,270
Common stock issued upon exercise of stock options, shares 51,100          
Common stock issued pursuant to employee stock purchase plan $ 96 15,356 15,452 15,452
Common stock issued pursuant to employee stock purchase plan, shares 9,618          
Common stock issued in at-the-market offering, net of offering expenses $ 32,613 7,833,427 7,866,040 7,866,040
Common stock issued in at-the-market offering, net of offering expenses, shares 3,261,282          
Net loss (7,794,320) (7,794,320) (57,032) (7,851,352)
Ending balance at Jul. 31, 2020 $ 236,537 197,993,060 (189,611,583) 8,618,014 (480,007) 8,138,007
Ending balance, shares at Jul. 31, 2020 23,653,754          
Beginning balance at Apr. 30, 2020 $ 214,793 192,122,260 (187,049,899) 5,287,154 (464,904) 4,822,250
Beginning balance, shares at Apr. 30, 2020 21,479,335          
Stock option compensation to employees and directors 997,094 997,094 997,094
Stock options issued to consultants 44,705 44,705 44,705
Common stock issued upon exercise of stock options $ 72 18,468 18,540 18,540
Common stock issued upon exercise of stock options, shares 7,200          
Common stock issued in at-the-market offering, net of offering expenses $ 21,672 4,810,533 4,832,205 4,832,205
Common stock issued in at-the-market offering, net of offering expenses, shares 2,167,219          
Net loss (2,561,684) (2,561,684) (15,103) (2,576,787)
Ending balance at Jul. 31, 2020 $ 236,537 $ 197,993,060 $ (189,611,583) $ 8,618,014 $ (480,007) $ 8,138,007
Ending balance, shares at Jul. 31, 2020 23,653,754